Babar Ahmad
Internal Medicine · Lansing, MINPI 1619081684
Payments from drug & device makers
Across 61 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$261
- Welch Allyn$192
- Astellas Pharma US Inc$100
- Pfizer$97
- Novo Nordisk$79
- Boehringer Ingelheim$53
- plus $431 from 22 others
What the payments were for
- Food & beverage$92076%
- Education$1008%
- Other$19216%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 16 | $261 |
| Welch Allyn | 1 | $192 |
| Astellas Pharma US Inc | 1 | $100 |
| Pfizer | 6 | $97 |
| Novo Nordisk | 5 | $79 |
| Boehringer Ingelheim | 4 | $53 |
| GSK | 2 | $46 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Nestle Healthcare Nutrition Inc. | 2 | $28 |
| Insulet Corporation | 2 | $28 |
| AstraZeneca | 1 | $23 |
| Merck | 2 | $22 |
| Clarus Therapeutics Inc. | 1 | $20 |
| Nevro Corp. | 1 | $19 |
| Medtronic | 1 | $16 |
| AbbVie | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Bayer | 1 | $13 |
| Amgen | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
| Daiichi Sankyo Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$192
How this compares
$1,212 in reported general payments places this provider in the 75th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 38 | $80,924 |
| EliquisApixaban | 17 | $23,552 |
| JardianceEmpagliflozin | 24 | $19,043 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $5,061 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,730 |
| Rosuvastatin Calcium | 137 | $2,272 |
| Felodipine ErFelodipine | 44 | $1,633 |
| Losartan Potassium | 116 | $1,492 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 46 | $1,452 |
| Atorvastatin Calcium | 120 | $1,427 |
| Tamsulosin Hcl | 63 | $1,404 |
| Metoprolol Succinate | 73 | $1,168 |
| Levothyroxine Sodium | 102 | $1,154 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $1,028 |
| Montelukast Sodium | 52 | $865 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $34 | $80,92438 claims |
| PfizerEliquis | $97 | $23,55217 claims |
| Boehringer IngelheimJardiance | $53 | $19,04324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Lansing
- Ulka VaishampayanAnn Arbor$33.7M
- Jeffrey PottsBay City$14.7M
- Neil FraserTroy$14.3M
- Abdulhassan SaadDearborn$11.5M
- Leslie PelkeyGrand Rapids$8.5M
- Jay SandbergTroy$8.3M
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Ahmed ArifFlint$4.1M
- Sudipto MukherjeeRoyal Oak$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.